NL-OMON28712招募中不适用
Antibody guided therapy in patients with primary membranous nephropathy (MN)
Radboud UMC Nijmegen0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •patients with primary membranous nephropathy
- •- 18 years or older
排除标准
- •- anti-PLA2R antibodies negative
- •- participation in another clinical trial
研究者
相似试验
进行中（未招募）
1 期
Complex immunomodulatory therapy for patients with immune thrombocytopenia (T-MEM)Immune thrombocytopeniaMedDRA version: 23.0Level: PTClassification code: 10083842Term: Immune thrombocytopenia Class: 100000004851CTIS2023-505788-35-00Fakultni Nemocnice Hradec Kralove73
已完成
1 期
A combination immunotherapy for the patients with advanced or metastatic solid cancersolid cancerJPRN-UMIN000020440Yamaguchi university Graduate School of Medicine17
招募中
1 期
Efficay of immunotherapy berfore surgery for localized dMMR colon cancerPatients with early stage (stage I-III) dMMR colon cancerMedDRA version: 21.0Level: LLTClassification code 10009951Term: Colon cancer NOSSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-006046-12-DKRigshospitalet85
进行中（未招募）
1 期
Monoclonal antibodies for treatment of bone marrow cancer. multiple myeloma.MedDRA version: 19.1Level: LLTClassification code 10028567Term: Myeloma, malignantSystem Organ Class: 100000004864Multiple MyelomaEUCTR2014-005189-31-DKDept Hematology SLB Vejle60
Enrolling By Invitation
不适用
Treatment of patients with immune-related adverse events after checkpoint inhibitors with extracorporeal photopheresis (ECP): a retrospective analysis and translational studiesImmune-related adverse events (colitis, hepatitis, dermatitis, arthralgia) after treatment with immune checkpoint inhibitors (antibodies against PD-1, PD-L1 and CTLA4).DRKS00026642niversitätsklinikum Freiburg20